Literature DB >> 887795

Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization.

R R Gorman, F F Sun, O V Miller, R A Johnson.   

Abstract

An easy biochemical preparation of the prostaglandin endoperoxides, PGH1 and PGH2, is described. Both of the endoperoxides are potent contractors of isolated gerbil colon smooth muscle. Contracture with PGH2 is about equal to that caused by the standard, PGE1, while contracture with PGH1 is about half of that caused by PGE1. PGH1 was found to inhibit platelet aggregation induced by PGH2 and is about 1/10 as potent a stimulator of cAMP accumulation as is PGE1. The mass spectra of the methyl esters of both PGH1 and PGH2 were obtained, as were the infrared spectra of the two compounds. The nuclear magnetic resonance spectrum of PGH2 is characterized by signals at 4.58 delta and 4.47 delta for the C-9 and C-11 protons, respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 887795     DOI: 10.1016/0090-6980(77)90132-0

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  13 in total

1.  U-46619, a selective thromboxane A2-like agonist? [proceedings].

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

2.  Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.

Authors:  M O Whitaker; A Wyche; F Fitzpatrick; H Sprecher; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential.

Authors:  F A Fitzpatrick; D A Stringfellow
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

4.  Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.

Authors:  R A Coleman; P P Humphrey; I Kennedy; G P Levy; P Lumley
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

5.  Platelet and blood vessel arachidonate metabolism and interactions.

Authors:  P Needleman; A Wyche; A Raz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

6.  Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.

Authors:  N K Hopkins; R R Gorman
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

7.  Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.

Authors:  P Needleman; S D Bronson; A Wyche; M Sivakoff; K C Nicolaou
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase.

Authors:  A F Brotherton; J C Hoak
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium.

Authors:  A F Brotherton; J C Hoak
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidylinositol metabolism and arachidonic acid release in human platelets.

Authors:  S E Rittenhouse; C L Allen
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.